Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

The Pfizer and Moderna shots are formulated against a virus subtype called KP.2 while the Novavax vaccine targets its parent strain, JN.1. Daskalakis said all should offer good cross protection to ...

While it is too early to know how this season’s flu will play out, we do know that COVID-19 is still with us.’ ...

Take a tour of a COVID-19 vaccine manufacturing facility in Montreal Francois-Philippe Champagne, federal minister of ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

The Novavax vaccine targets the JN ... and there’s no particular reason to think it would be any different with the latest ...

Anyone with COVID-19 during the summer has some, but not full, protection against germs spreading in fall and winter.

The CDC lowered the age for the pneumonia vaccination from 65 to 50 and recommended an extra COVID shot to some people.

But he noted that the circulating variants are not that different from the Novavax’s JN.1 target and that many of the antibodies people will make in response to the updated vaccines are aimed at ...

But he noted that the circulating variants are not that different from the Novavax’s JN.1 target and that many of the ...

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined Covid-flu vaccine and standalone flu inoculation due to safety concerns.